Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Letters to the Editor

Mesothelin Is Shed from Tumor Cells

Mitchell Ho, Masanori Onda, Qing-cheng Wang, Raffit Hassan, Ira Pastan and Mark O. Lively
Mitchell Ho
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masanori Onda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qing-cheng Wang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raffit Hassan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ira Pastan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark O. Lively
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-06-0479 Published September 2006
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: September 2006 to March 2021

AbstractFull-text HTMLPDF
Total024931111

Cited By

Article Information

Volume 15, Issue 9, pp. 1751

DOI 
https://doi.org/10.1158/1055-9965.EPI-06-0479
PubMed 
16985043

Published By 
American Association for Cancer Research
Print ISSN 
1055-9965
Online ISSN 
1538-7755
History 
  • Published first September 19, 2006.

Copyright & Usage 
American Association for Cancer Research

Author Information

  1. Mitchell Ho,
  2. Masanori Onda,
  3. Qing-cheng Wang,
  4. Raffit Hassan and
  5. Ira Pastan
  1. Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland
  1. Mark O. Lively
  1. Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, North Carolina
    PreviousNext
    Back to top
    Cancer Epidemiology Biomarkers & Prevention: 15 (9)
    September 2006
    Volume 15, Issue 9
    • Table of Contents
    • Table of Contents (PDF)

    Sign up for alerts

    View this article with LENS

    Open full page PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    Mesothelin Is Shed from Tumor Cells
    (Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
    (Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Mesothelin Is Shed from Tumor Cells
    Mitchell Ho, Masanori Onda, Qing-cheng Wang, Raffit Hassan, Ira Pastan and Mark O. Lively
    Cancer Epidemiol Biomarkers Prev September 1 2006 (15) (9) 1751; DOI: 10.1158/1055-9965.EPI-06-0479

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    Mesothelin Is Shed from Tumor Cells
    Mitchell Ho, Masanori Onda, Qing-cheng Wang, Raffit Hassan, Ira Pastan and Mark O. Lively
    Cancer Epidemiol Biomarkers Prev September 1 2006 (15) (9) 1751; DOI: 10.1158/1055-9965.EPI-06-0479
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • References
    • Figures & Data
    • Info & Metrics
    • PDF
    Advertisement

    Related Articles

    Cited By...

    More in this TOC Section

    • Copy Number Variation and Ovarian Cancer Risk—Letter
    • Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer Risk—Response
    • Shift Work, Chronotype, and Cancer Risk—Response
    Show more Letters to the Editor
    • Home
    • Alerts
    • Feedback
    • Privacy Policy
    Facebook   Twitter   LinkedIn   YouTube   RSS

    Articles

    • Online First
    • Current Issue
    • Past Issues

    Info for

    • Authors
    • Subscribers
    • Advertisers
    • Librarians

    About Cancer Epidemiology, Biomarkers & Prevention

    • About the Journal
    • Editorial Board
    • Permissions
    • Submit a Manuscript
    AACR logo

    Copyright © 2021 by the American Association for Cancer Research.

    Cancer Epidemiology, Biomarkers & Prevention
    eISSN: 1538-7755
    ISSN: 1055-9965

    Advertisement